Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Frontiers | Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease
Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition | Nature Communications
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives | SpringerLink
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
Measuring the Brain's Amyloid Buildup Less Effective in Identifying Severity, Progression of Alzheimer's Disease Compared to Other Imaging Methods - Penn Medicine
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Frontiers | Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals
The amyloid cascade hypothesis: are we poised for success or failure? - Karran - 2016 - Journal of Neurochemistry - Wiley Online Library
IJMS | Free Full-Text | Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease
Clinical significance of fluid biomarkers in Alzheimer's Disease | SpringerLink
Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor | ACS Applied Materials & Interfaces
The complexity of Alzheimer's disease: an evolving puzzle | Physiological Reviews
Frontiers | Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study - The Lancet Neurology
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease | Science Advances
JPM | Free Full-Text | Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer's Disease
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
IJMS | Free Full-Text | Amyloid Beta in Aging and Alzheimer’s Disease
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
